Skip to content

Prime Medicine PRME Operating Income

Operating Income at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.14B+80.6%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
-$100.53M+16.8%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-$130.25M+12.2%
Beam Therapeutics logo
Beam TherapeuticsBEAM
-$107.22M+10.1%
Regenxbio logo
RegenxbioRGNX
-$83.36M-787%
Sana Biotechnology logo
Sana BiotechnologySANA
-$48.61M+4.0%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Net income-$49.1M+5.3%
EPS (diluted)-$0.28+30.0%

Balance sheet

See full
Cash & equivalents$77.8M-26.6%
Total debt$114.5M-5.5%
Total equity$76.7M-28.3%
Total assets$294.7M-10.2%

Cash flow

See full
Operating cash flow-$42.7M+12.6%
CapEx$214.0K-91.2%
Free cash flow-$42.9M+16.3%

Valuation

See full
Market cap$574.36M+111%
Enterprise value$611.08M+113%
P/S124×+6.3×

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-216.1%+1,519pp
Debt / equity1.5×+0.4×
Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prime Medicine's operating income?
Prime Medicine (PRME) reported operating income of -$50.65M in Q1 2026.
How has Prime Medicine's operating income changed year-over-year?
Prime Medicine's operating income increased by 3.3% year-over-year, from -$52.39M to -$50.65M.
What is the long-term trend for Prime Medicine's operating income?
Over 3 years (2022 to 2025), Prime Medicine's operating income has grown at a 21.4% compound annual growth rate (CAGR), from -$116.54M to -$208.35M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.